Analysts Viewpoint
SPRO’s short interest shows a sharp rise on 2025-05-30
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Spero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Keutzer Timothy unloaded Company’s shares for reported $44099.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its